In the same vein, Sun et al. reported that EMPA improved obesity-related cardiac dysfunction via promoting Sesn2-mediated AMPK-mTOR signaling and Sesn2-induced Nrf2 activation by enhancing the autophagic degradation of Keap1 [55]. The gene discussed is KEAP1; the disease is obesity disorder.